0 Products

cart is empty


Offering Strain Specific “Designer Highs”

ABSTRAX Announces Cannabis Analysis Services and Custom Terpene Formulations for Brands Seeking to Offer Strain Specific “Designer Highs”

Groundbreaking Cannabis Profiling Technology Allows for Biomimicry, Proven Consistency, Quality, and Predictable Effects for Brands Seeking Exclusive Custom Formulations

IRVINE - April 20, 2020 - ABSTRAX, a leader in the research and production of botanical and cannabis-derived terpenes, announces its advanced cannabis analytical testing program and custom strain specific terpene formulations for leading and emerging cannabis brands. Its proprietary strain profiling technology including 3D Metabolite Fingerprint™ and custom formulation system allows for unparalleled cannabis analytics to harness the power of the plant and create unmatched terpene formulations. This advancement in cannabis science allows us the ability to create functional strain specific cannabis product formulations that build consumer trust achieved by our scientific approach needed to create predictable and repeatable experiences that can further enhance brand power.

“We’re now able to study the most popular genetics to formulate ‘Designer Highs’ for brands looking to offer their customers all-natural, terpene-driven sensorial experiences that they will never forget,” says Max Koby, Founding Partner and Chief Executive Officer of ABSTRAX. “And the beauty is that these experiences produced by cannabis can now be replicated and steered by non-cannabis, botanically-derived terpenes and aroma compounds that are completely identical,  THC-free and can be shipped and enjoyed nearly anywhere in the world.”

ABSTRAX has made this possible after years of partnership with the best cultivation partners to analyze hundreds of strains and map over 400 terpenes and aroma compounds that provide the unique attributes of each chemovar. We have focused our R&D program on discovering and researchingnew and novel compounds that create distinct flavors, aromas, and contribute to the well-documented effects of common cannabis strains including Jack Herer, OG’s, and Gelato. “What makes our research so unique is that we identify and quantify these valuable compounds and then re-create cannabis profiles by developing scientifically based, unparalleled testing standards incorporated with a sensory panel comprised of industry experts to capture each cannabis essence and aroma,” says Kevin Koby, Chief Science Officer of ABSTRAX. 

“Our 3D metabolite fingerprint technology and proprietary formulation system is a complete game-changer. We can now develop botanical formulations that are strain specific, authentic, and unwaveringly consistent. Now consumers don’t have to question how a particular strain will affect their minds and bodies. We are able to drill down the specifics of each strain’s unique attributes and reproduce predictable and repeatable results that build consumer trust,” says Koby.

This technology comes at a time in which cannabis scientists around the world are chasing “the perfect high” and seeking to create more effective, predictable and reliable product experiences. This has been a difficult code to crack because cannabis is an extremely complex plant and scientists are consistently finding that terpenes play a major role in the overall effects of cannabinoids.

ABSTRAX has started a research initiative to further elucidate how the entourage effect works and seeks to prove the benefits of terpenes in different combinations. We have partnered with Dr. Josh Kaplan from Western Washington University to study the effects of combining both major and minor terpenoids common in cannabis to further support the entourage theory in search of the perfect high.  

In fact, the Colorado-based medicinal cannabis research company EBBU was recently purchased for more than $300 Million because of its ability to produce a consistent, “happy high”, one that is backed by data surrounding user experience, breeding specific ratios of cannabinoids/terpenes, and formulating according to how terpenes interact with one another and the desired effect they create.

“We’re at a fascinating time, as we’re now able to use lab generated data like never before to certifiably know what consumers desire and which combinations of compounds can be counted on to give them what they want. This is what sets us apart from our competitors, as we live and breathe a powerful combination of data, science, innovation, and safety-driven procedures that the brands we work with can count on,” says Koby.

In an effort to provide its customers valuable intellectual property, customized products and services, ABSTRAX’s R&D and custom formulation program offers the following features, checks and balances:

  • ABSTRAX’S cannabis strain analysis is the most advanced and comprehensive method to achieve biomimicry of each cannabis variety and build valuable IP for brands

  • Its R&D team includes PhD research scientists, analytical chemists, formulation chemists, and cannabis connoisseurs working together to discover the nuances of cannabis and create the most authentic, strain-specific formulations available.

  • Once new compounds are discovered we take a deeper dive into researching their potential benefits and applications.

  • All ingredients are sourced from botanical and naturally-derived sources, unless unavailable and approved by a customer.

  • ABSTRAX continually sources hundreds of natural isolates for its formulations and is always seeking new sources for the rare compounds its team discovers.

  • All incoming materials, isolates, and blends are subject to strict compliance standards, and GC purity and residual solvent analysis.
  • ABSTRAX maintains ingredient standardization including GC analysis and molecular distillation of natural raw materials to increase purity and consistency.

  • Provides a COA and compliance package for all products and full lot traceability.

ABSTRAX is already working with a select number of brands including Sherbinskis, Jack Herer, and JoshD developing custom formulations that are exclusive and can be used to help license their proprietary genetics and formulations across state boundaries. Its custom formulation program is expected to grow exponentially as it is now opening up to the food and beverage and cannabis industries at large.

“As we work to grow our custom formulation program, we’re confident that our work with leading universities, researchers, and our state-of-the-art laboratory will play a pivotal role in forever changing the way humanity interacts with cannabis aroma compounds, flavors, and the desired effects. Whether a customer is seeking greater relaxation, more laughter, a burst of energy, or other effects from the products they use, we understand that they are ultimately buying experiences, and we’re here to support the brands that serve them,” says Koby.


Leveraging its proven background in cannabis research, ABSTRAX is the leader in the research, development, and production of cannabis and botanically-derived terpenes that create unforgettable sensorial experiences. Headquartered in California, the company owns and operates a state-of-the-art type 7 licensed research and manufacturing lab where it’s award-winning product developers and scientists leverage the most advanced strain analysis technology to extract and study aroma compounds via three-dimensional analysis, allowing for each and every compound within a plant to be named and studied. The company has partnered with many of the best cultivators in the industry to study their cannabis profiles and create the world's most advanced terpene formulations. As a result of its efforts, ABSTRAX offers the largest terpene catalogue of the most popular strains - botanically-derived terpene blends and isolates native to cannabis. These ingredients, also known as functional flavors and aromas, are used in vapes, concentrates, edibles, beer, essential oils, fragrances, cosmetics, topicals, tinctures, alcohol, food and beverage, personal care, and more. The company works with internationally recognized brands and provides unparalleled cannabis research, innovation, and custom formulations to create products that engage and thrill consumers. ABSTRAX also devotes significant resources to developing the highest terpene standards and best practices in the industry. The company has developed a robust quality management system including Gas Chromatography analysis and molecular distillation of natural ingredients to achieve the highest purity standards. Investigating and ensuring that ingredients used in its own products, and products within its industry, are safe for consumption. The terpene industry is a rapidly growing segment of the global flavor and fragrance market, which is expected to grow to $35 billion by 2024. This market segment includes the cannabis, CBD, skincare, cosmetics, health and wellness, food and beverage industries. For more information, visit


Media Contact:

Stacey Kaszton Jones
La Voz Marketing
213.925.8177 (direct)

See other TERPENES news

Abstrax Announces World's Largest Cannabis Hydrocarbon Extractor, Revolutionizing California Toll Processing

Extractor capable of processing every grow in CA annually, offers competitive pricing, and handles trim and biomass so growers don't...

read article

Abstrax and Seed Talent Partner for First of Its Kind Advanced Terpene Education and Exclusive Terpene Science Courses

Terpene flavor and aroma education courses will empower retailers to unlock new levels of sales expertise and knowledge in the...

read article

Abstrax Revolutionizes Cannabis Aroma Science with the Discovery of Tropicannasulfur Compounds (TCSCs)

Abstrax unveils the elusive chemical magic behind favorite citrus and tropical cannabis scents, reshaping the industry's understanding of aroma in...

read article

Abstrax and Western Washington University Unveil Groundbreaking Research Paper on CBD and Terpene Blends for Autism Spectrum Disorder

Researchers anticipate findings will ignite further investigations and establish a pathway toward more effective treatments for individuals on the autism...

read article

Abstrax and AVD Advance Inhalation Safety for the Cannabis Industry

Abstrax partners with AVD and McKinney Regulatory Science Advisors to launch a state-of-the-art toxicology program that addresses data gaps and...

read article

Abstrax Unveils the Intriguing Chemistry Behind Savory Cannabis Aromas

Revelatory white paper shows surprising link between cannabis aromas and a compound also found in nature's palette: a foul-smelling element...

read article

Abstrax Discovers New Exotic Flavor Compounds and Cannabis’ Hidden Flavor Spectrum: Beyond Terpenes to a World of Sweet Savory Citrus and Fruity Flavorants

Redefining the aromatic landscape: Abstrax's pioneering research in collaboration with industry leader 710 Labs reveals untapped dimensions of cannabis essence...

read article

Abstrax and Weedmaps Partner to Pioneer a New Era of Cannabis Research and Science

Weedmaps to produce educational content series based on Abstrax’s game-changing discoveries and products TUSTIN, Calif. -- Abstrax, the leader in...

read article

Abstrax Partners with Leading Hemp Supplier Terplandia to Provide the Highest Quality Natural Hemp Terpenes to the Market

The strategic partnership sets the stage for continued innovation and development of terpene and flavor-focused hemp genetics while empowering customers...

read article

ABSTRAX Releases White Paper That Details Its Role in Keeping Butane Hash Oil (BHO) Extraction Legal in Canada

ABSTRAX leverages extensive research to convince legislators to maintain hydrocarbon extraction in the legal cannabis landscape to improve safety measures...

read article